Grant Number:	1R01CA127642-01A1 Interpret this number
Primary Investigator:	Lipshultz, Steven
Organization:	University Of Miami School Of Medicine
Project Title:	Genetic Mechanisms of Anthracycline Cardiotoxicity in Pediatric Cancer Survivors
Fiscal Year:	2007

DESCRIPTION (provided by applicant): Long-term survivors of childhood cancer (LTS) have greater than an 8-fold increased risk of CV mortality compared to a healthy population 25 years after therapy. This risk increases progressively over time and appears related in part to anthracycline chemotherapy. Since 1:570 young adults in the US aged 20-45 by 2010 is projected to be a childhood cancer survivor and half will have had anthracycline therapy, the mechanism of this toxicity to prevent or treat it becomes critical to understand. Genetics (either natural genotypes or induced changes) may play a role in the susceptibility of anthracycline toxicity for each individual. In animal models of anthracycline cardiotoxicity, irreversible mitochondrial impairment, in part related to free-radical injury during therapy, leading to late cardiomyopathy is found but this has not been studied in humans. Mutations of the genes know to cause hemochromatosis (HFE mutations) may also lead to susceptibility to toxicity. In this application, Aim 1 will be to determine the frequency of mitochondrial DNA (mtDNA) mutations in pediatric acute lymphoblastic leukemia (ALL) survivors enrolled in the Dana Farber Cancer Institute Consortium. We will also determine if there are differences in mutation rates between children who received the cardioprotectant, dexrazoxane, versus those who did not. We will correlate the degree of mutations to other markers of cardiac function (echocardiographic measures and serum biomarkers of cardiac risk). Aim 2 will determine if HFE mutations are associated with greater long-term cardiotoxicity as measured by echocardiography and serum biomarkers. We will enroll a total of 200 ALL survivors enrolled in the DFCI ALL consortium who were enrolled in studies 91-001, 95-001, and 00-001. Only 50% will have received the cardioprotectant, dexrazoxane. mtDNA and HFE studies will be obtained >4 years from diagnosis with simultaneous evaluation of cardiac function via echocardiography and analysis of serum biomarkers of cardiac risk (lipids, proBNP, hsCRP, cTnT). We will determine: 1. If there is a higher frequency of mtDNA mutations associated with prior anthracycline treatment and if dexrazoxane is protective against these mutations 2. If mtDNA mutation relate to increased CV risk of cardiomyopathy, premature atherosclerosis; 3. If the HFE mutations are related to increased cardiotoxicity of anthracyclines. This study will elucidate the molecular mechanisms of anthracycline cardiotoxicity in pediatric ALL cancer survivors.




Mutational analysis of the mitochondrial tRNA genes and flanking regions in lymphocytes from long-term pediatric cancer survivors given doxorubicin chemotherapy for acute lymphoblastic leukemia.
Authors: Walker V.E. , Bansal N. , Torres S.M. , Stevenson K. , Flamand Y. , Walker D.M. , Sallan S.E. , Lipshultz S.E. .
Source: Cardio-oncology (london, England), 2025-11-03 00:00:00.0; 11(1), p. 99.
EPub date: 2025-11-03 00:00:00.0.
PMID: 41185077
Related Citations

Metabolic and Bariatric Surgery Utilization in the Era of Glucagon-Like Peptide-1 Receptor Agonists among Adolescents versus Adults.
Authors: Messiah S.E. , Ernest D.K. , Atem F.D. , Qureshi F.G. , Mathew M.S. , Francis J.M. , Wheelington A. , Allicock M.A. , Cartwright B.R. , Schneider B.E. , et al. .
Source: The Journal Of Pediatrics, 2025 Jul; 282, p. 114564.
EPub date: 2025-03-23 00:00:00.0.
PMID: 40132747
Related Citations

Reply.
Authors: Messiah S.E. , Ernest D.K. , Cruz-Muñoz N. , Lipshultz S.E. , Barlow S.E. .
Source: The Journal Of Pediatrics, 2025-04-28 00:00:00.0; , p. 114616.
EPub date: 2025-04-28 00:00:00.0.
PMID: 40306547
Related Citations

Genomics of pediatric cardiomyopathy.
Authors: Lee T.M. , Ware S.M. , Kamsheh A.M. , Bhatnagar S. , Absi M. , Miller E. , Purevjav E. , Ryan K.A. , Towbin J.A. , Lipshultz S.E. .
Source: Pediatric Research, 2025 Mar; 97(4), p. 1381-1392.
EPub date: 2025-02-08 00:00:00.0.
PMID: 39922924
Related Citations

Long-Term Outcomes after Adolescent Bariatric Surgery.
Authors: de la Cruz-Muñoz N. , Xie L. , Quiroz H.J. , Kutlu O.C. , Atem F. , Lipshultz S.E. , Mathew M.S. , Messiah S.E. .
Source: Journal Of The American College Of Surgeons, 2022-10-01 00:00:00.0; 235(4), p. 592-602.
EPub date: 2022-09-15 00:00:00.0.
PMID: 36102560
Related Citations

Cardiovascular diseases in survivors of childhood cancer.
Authors: Bansal N. , Blanco J.G. , Sharma U.C. , Pokharel S. , Shisler S. , Lipshultz S.E. .
Source: Cancer Metastasis Reviews, 2020 Mar; 39(1), p. 55-68.
PMID: 32026204
Related Citations

Upfront dexrazoxane for the reduction of anthracycline-induced cardiotoxicity in adults with preexisting cardiomyopathy and cancer: a consecutive case series.
Authors: Ganatra S. , Nohria A. , Shah S. , Groarke J.D. , Sharma A. , Venesy D. , Patten R. , Gunturu K. , Zarwan C. , Neilan T.G. , et al. .
Source: Cardio-oncology (london, England), 2019; 5, p. 1.
EPub date: 2019-01-29 00:00:00.0.
PMID: 32154008
Related Citations

When is early septal myectomy in children with hypertrophic cardiomyopathy justified?
Authors: Bansal N. , Barach P. , Amdani S.M. , Lipshultz S.E. .
Source: Translational Pediatrics, 2018 Oct; 7(4), p. 362-366.
PMID: 30460188
Related Citations

Letter by Lipshultz Regarding Article, "Anthracycline Cardiotoxicity: Worrisome Enough to Have You Quaking?"
Authors: Lipshultz S.E. .
Source: Circulation Research, 2018-03-30 00:00:00.0; 122(7), p. e62-e63.
PMID: 29599279
Related Citations

Anthracycline cardiotoxicity: the importance of horizontally integrating pre-clinical and clinical research.
Authors: Lipshultz S.E. , Herman E.H. .
Source: Cardiovascular Research, 2018-02-01 00:00:00.0; 114(2), p. 205-209.
PMID: 29272330
Related Citations

Risk of Coronary Events 55 Years after Thymic Irradiation in the Hempelmann Cohort.
Authors: Adams M.J. , Fisher S.G. , Lipshultz S.E. , Shore R.E. , Constine L.S. , Stovall M. , Dozier A. , Thevenet-Morrison K. , Block R. , Schwartz R.G. , et al. .
Source: Cardio-oncology (london, England), 2018; 4, .
EPub date: 2018-02-17 00:00:00.0.
PMID: 30381795
Related Citations

Prevention of cardiotoxicity among survivors of childhood cancer.
Authors: Hutchins K.K. , Siddeek H. , Franco V.I. , Lipshultz S.E. .
Source: British Journal Of Clinical Pharmacology, 2017 03; 83(3), p. 455-465.
EPub date: 2016-10-12 00:00:00.0.
PMID: 27591829
Related Citations

The Safety of Ingested Caffeine: A Comprehensive Review.
Authors: Temple J.L. , Bernard C. , Lipshultz S.E. , Czachor J.D. , Westphal J.A. , Mestre M.A. .
Source: Frontiers In Psychiatry, 2017; 8, p. 80.
EPub date: 2017-05-26 00:00:00.0.
PMID: 28603504
Related Citations

Impaired mitochondrial function is abrogated by dexrazoxane in doxorubicin-treated childhood acute lymphoblastic leukemia survivors.
Authors: Lipshultz S.E. , Anderson L.M. , Miller T.L. , Gerschenson M. , Stevenson K.E. , Neuberg D.S. , Franco V.I. , LiButti D.E. , Silverman L.B. , Vrooman L.M. , et al. .
Source: Cancer, 2016-03-15 00:00:00.0; 122(6), p. 946-53.
EPub date: 2016-03-15 00:00:00.0.
PMID: 26762648
Related Citations

Cardiac Complications In Childhood Cancer Survivors Treated With Anthracyclines
Authors: Franco V.I. , Lipshultz S.E. .
Source: Cardiology In The Young, 2015 Aug; 25 Suppl 2, p. 107-16.
PMID: 26377717
Related Citations

Cardiovascular Disease In Adult Survivors Of Childhood Cancer
Authors: Lipshultz S.E. , Franco V.I. , Miller T.L. , Colan S.D. , Sallan S.E. .
Source: Annual Review Of Medicine, 2015; 66, p. 161-76.
PMID: 25587648
Related Citations

Issues In Solid-organ Transplantation In Children: Translational Research From Bench To Bedside
Authors: Lipshultz S.E. , Chandar J.J. , Rusconi P.G. , Fornoni A. , Abitbol C.L. , Burke G.W. , Zilleruelo G.E. , Pham S.M. , Perez E.E. , Karnik R. , et al. .
Source: Clinics (sa¿o Paulo, Brazil), 2014; 69 Suppl 1, p. 55-72.
PMID: 24860861
Related Citations

Treatment-related Cardiotoxicity In Survivors Of Childhood Cancer
Authors: Lipshultz S.E. , Cochran T.R. , Franco V.I. , Miller T.L. .
Source: Nature Reviews. Clinical Oncology, 2013 Dec; 10(12), p. 697-710.
PMID: 24165948
Related Citations

Impact of hemochromatosis gene mutations on cardiac status in doxorubicin-treated survivors of childhood high-risk leukemia.
Authors: Lipshultz S.E. , Lipsitz S.R. , Kutok J.L. , Miller T.L. , Colan S.D. , Neuberg D.S. , Stevenson K.E. , Fleming M.D. , Sallan S.E. , Franco V.I. , et al. .
Source: Cancer, 2013-10-01 00:00:00.0; 119(19), p. 3555-62.
EPub date: 2013-10-01 00:00:00.0.
PMID: 23861158
Related Citations

Ingesting And Aspirating Dry Cinnamon By Children And Adolescents: The "cinnamon Challenge"
Authors: Grant-Alfieri A. , Schaechter J. , Lipshultz S.E. .
Source: Pediatrics, 2013 May; 131(5), p. 833-5.
PMID: 23610205
Related Citations

Cranial irradiation as an additional risk factor for anthracycline cardiotoxicity in childhood cancer survivors: an analysis from the cardiac risk factors in childhood cancer survivors study.
Authors: Landy D.C. , Miller T.L. , Lipsitz S.R. , Lopez-Mitnik G. , Hinkle A.S. , Constine L.S. , Adams M.J. , Lipshultz S.E. .
Source: Pediatric Cardiology, 2013 Apr; 34(4), p. 826-34.
PMID: 23080542
Related Citations

Exercise capacity in long-term survivors of pediatric cancer: an analysis from the Cardiac Risk Factors in Childhood Cancer Survivors Study.
Authors: Miller A.M. , Lopez-Mitnik G. , Somarriba G. , Lipsitz S.R. , Hinkle A.S. , Constine L.S. , Lipshultz S.E. , Miller T.L. .
Source: Pediatric Blood & Cancer, 2013 Apr; 60(4), p. 663-8.
PMID: 23255294
Related Citations

Dietary quality, caloric intake, and adiposity of childhood cancer survivors and their siblings: an analysis from the cardiac risk factors in childhood cancer survivors study.
Authors: Landy D.C. , Lipsitz S.R. , Kurtz J.M. , Hinkle A.S. , Constine L.S. , Adams M.J. , Lipshultz S.E. , Miller T.L. .
Source: Nutrition And Cancer, 2013; 65(4), p. 547-55.
PMID: 23659446
Related Citations

Continuous Versus Bolus Infusion Of Doxorubicin In Children With All: Long-term Cardiac Outcomes
Authors: Lipshultz S.E. , Miller T.L. , Lipsitz S.R. , Neuberg D.S. , Dahlberg S.E. , Colan S.D. , Silverman L.B. , Henkel J.M. , Franco V.I. , Cushman L.L. , et al. .
Source: Pediatrics, 2012 Dec; 130(6), p. 1003-11.
PMID: 23166343
Related Citations

Cardiac failure 30 years after treatment containing anthracycline for childhood acute lymphoblastic leukemia.
Authors: Goldberg J.M. , Scully R.E. , Sallan S.E. , Lipshultz S.E. .
Source: Journal Of Pediatric Hematology/oncology, 2012 Jul; 34(5), p. 395-7.
PMID: 22584777
Related Citations

Cardiotoxicity in childhood cancer survivors: strategies for prevention and management.
Authors: Harake D. , Franco V.I. , Henkel J.M. , Miller T.L. , Lipshultz S.E. .
Source: Future Cardiology, 2012 Jul; 8(4), p. 647-70.
PMID: 22871201
Related Citations

Changes In Cardiac Biomarkers During Doxorubicin Treatment Of Pediatric Patients With High-risk Acute Lymphoblastic Leukemia: Associations With Long-term Echocardiographic Outcomes
Authors: Lipshultz,S.E. , Miller,T.L. , Scully,R.E. , Lipsitz,S.R. , Rifai,N. , Silverman,L.B. , Colan,S.D. , Neuberg,D.S. , Dahlberg,S.E. , Henkel,J.M. , et al. .
Source: Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology, 2012-04-01 00:00:00.0; 30(10), p. 1042-9.
PMID: 22370326
Related Citations

Cardiovascular Status Of Childhood Cancer Survivors Exposed And Unexposed To Cardiotoxic Therapy
Authors: Lipshultz,S.E. , Landy,D.C. , Lopez-Mitnik,G. , Lipsitz,S.R. , Hinkle,A.S. , Constine,L.S. , French,C.A. , Rovitelli,A.M. , Proukou,C. , Adams,M.J. , et al. .
Source: Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology, 2012-04-01 00:00:00.0; 30(10), p. 1050-7.
PMID: 22393080
Related Citations

Aggregating traditional cardiovascular disease risk factors to assess the cardiometabolic health of childhood cancer survivors: an analysis from the Cardiac Risk Factors in Childhood Cancer Survivors Study.
Authors: Landy D.C. , Miller T.L. , Lopez-Mitnik G. , Lipsitz S.R. , Hinkle A.S. , Constine L.S. , French C.A. , Rovitelli A.M. , Adams M.J. , Lipshultz S.E. .
Source: American Heart Journal, 2012 Feb; 163(2), p. 295-301.e2.
PMID: 22305850
Related Citations

Health Effects Of Energy Drinks On Children, Adolescents, And Young Adults
Authors: Seifert,S.M. , Schaechter,J.L. , Hershorin,E.R. , Lipshultz,S.E. .
Source: Pediatrics, 2011 Mar; 127(3), p. 511-28.
PMID: 21321035
Related Citations

Assessment Of Dexrazoxane As A Cardioprotectant In Doxorubicin-treated Children With High-risk Acute Lymphoblastic Leukaemia: Long-term Follow-up Of A Prospective, Randomised, Multicentre Trial
Authors: Lipshultz,S.E. , Scully,R.E. , Lipsitz,S.R. , Sallan,S.E. , Silverman,L.B. , Miller,T.L. , Barry,E.V. , Asselin,B.L. , Athale,U. , Clavell,L.A. , et al. .
Source: The Lancet Oncology, 2010 Oct; 11(10), p. 950-61.
PMID: 20850381
Related Citations

Characteristics and determinants of adiposity in pediatric cancer survivors.
Authors: Miller T.L. , Lipsitz S.R. , Lopez-Mitnik G. , Hinkle A.S. , Constine L.S. , Adams M.J. , French C. , Proukou C. , Rovitelli A. , Lipshultz S.E. .
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2010 Aug; 19(8), p. 2013-22.
PMID: 20647396
Related Citations

Clinical Research Directions In Pediatric Cardiology
Authors: Lipshultz,S.E. , Wilkinson,J.D. , Messiah,S.E. , Miller,T.L. .
Source: Current Opinion In Pediatrics, 2009 Oct; 21(5), p. 585-93.
PMID: 19584723
Related Citations

Anthracycline associated cardiotoxicity in survivors of childhood cancer.
Authors: Lipshultz S.E. , Alvarez J.A. , Scully R.E. .
Source: Heart (british Cardiac Society), 2008 Apr; 94(4), p. 525-33.
PMID: 18347383
Related Citations